Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q2 2024 · 10-Q
Revenue$7.86M$7.86M+32.1% vs Q2 2023 Net Income-$4.41M-$4.41MN/M vs Q2 2023 EPS Diluted-$0.16-$0.16N/M vs Q2 2023 Gross Profit$4,988,000+59.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,668,000N/M Free Cash Flowderived-$2,668,000N/M Margins · derivedGross margin63.5%+10.9 pt vs Q2 2023
Operating margin-60.1%+59.7 pt vs Q2 2023
Net margin-56.1%+62.4 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 7, 2024 · 38 d after period end